Johnson & Johnson Innovation – JJDC has co-led the computational pathology technology provider's series C round to take its total funding to $195m.

Paige, a US-based medical diagnostics technology spinout of Memorial Sloan Kettering Cancer Center, has secured $100m in a series C round co-led by medical products group Johnson & Johnson’s investment arm, Johnson & Johnson Innovation – JJDC. Life sciences investment firm Casdin Capital co-led the round, which also featured undisclosed existing backers and investment funds.…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.